Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-25
1998-05-26
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546153, 546155, 546159, C07D40102, A61K 3147
Patent
active
057565171
ABSTRACT:
The present invention relates to the use of bisquinolines of the general formula ##STR1## in which the substituents mentioned have the meanings given in the description.
The invention furthermore relates to new bisquinolines of the general formula (I), to a process for the preparation of the known and the new bisquinolines, to the use of the new bisquinolines as medicaments, to their use for the preparation of medicaments, and to medicaments comprising them.
REFERENCES:
patent: 3362875 (1968-01-01), Strauss
patent: 3974279 (1976-08-01), Geizler
Bullock William
Chisholm Jane C.
Fanelli Richard J.
Feurer Achim
McCarthy Richard T.
Bayer Aktiengesellschaft
Davis Zinna Northington
LandOfFree
Use of bisquinoline compounds in the treatment of cerebral disor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of bisquinoline compounds in the treatment of cerebral disor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bisquinoline compounds in the treatment of cerebral disor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960518